76
|
Kurşun M, Nalbantgil S, Ertugay S, Engin C, Yağdı T, Özbaran M. The detection of cardiac tamponade by hemodynamic transesophageal echocardiography after left ventriculer assist device implantation. Anatol J Cardiol 2015; 15:438-9. [PMID: 25993727 PMCID: PMC5779199 DOI: 10.5152/akd.2015.6044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
|
77
|
Alkan MB, Bilgin M, Zihni B, Nalbantgil S. Unusual association of multiple congenital left ventricular diverticulum and cerebrovascular events in an adult. Turk Kardiyol Dern Ars 2015; 43:269-71. [PMID: 25905998 DOI: 10.5543/tkda.2015.68249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Congenital ventricular diverticulum is a rare and usually asymptomatic cardiac malformation which can cause major complications such as systemic thromboembolism, infective endocarditis, cardiac rupture, heart failure, arrhythmia and sudden death. We present a case with multiple congenital left ventricular diverticulum admitted to hospital with sudden onset right-sided hemiplegia and dysarthria.
Collapse
|
78
|
Simsek E, Nalbantgil S, Ceylan N, Zoghi M, Kemal H, Ertugay S, Engin C, Yagdi T, Ozbaran M. Infarct Atypical Late Gadolinium Enhancement in Cardiac Transplant Patients Predicts 3-Year Survival. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
79
|
Kemal H, Ertugay S, Kahraman U, Engin C, Nalbantgil S, Yagdi T, Ozbaran M. Impact of Residual Mitral Regurgitation on Right Ventricular Systolic Function After Left Ventricular Assist Device Implantation. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.455] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
80
|
Tuluce K, Yakar Tuluce S, Yavuzgil O, Isayev E, Bilgin M, Akyildiz Akcay F, Nalbantgil S, Ozerkan F. The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy. ACTA ACUST UNITED AC 2014; 14:719-27. [DOI: 10.5152/akd.2014.5101] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
81
|
Musayev O, Kayikcioglu M, Nalbantgil S, Mogulkoc N, Vuran O, Musayev K, Kultursay H. Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
82
|
Tülüce K, Tülüce S, Eren N, Nalbantgil S, Gürgün C, Özerkan F. OP-321 N-terminal-pro B Type Peptid Levels Correlate with Impaired Left Atrial Functions in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol 2014. [DOI: 10.1016/j.amjcard.2014.01.191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
83
|
Ozerkan F, Ozdogan O, Zoghi M, Nalbantgil S, Yavuzgil O, Remzi Önder M. Effects of atorvastatin 10 mg/d on insulin resistance: A 12-week, open-label study in hyperlipidemic patients. Curr Ther Res Clin Exp 2014; 67:44-54. [PMID: 24678082 DOI: 10.1016/j.curtheres.2006.02.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/07/2005] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND In addition to their cholesterol-lowering effects, hydroxymethylglutaryl coenzyme A reductase inhibitors ("statins") might have pleiotropic, nonlipid effects. Insulin resistance syndrome is known to increase the risk for cardiovascular disease. However, the effects of statins on insulin resistance are a subject of controversy. OBJECTIVE We aimed to investigate the effects of atorvastatin on insulin resistance in hyperlipidemic patients. METHODS This 12-week, prospective, nonrandomized, open-label study was conducted at the outpatient cardiology clinic, Ege University Medical School, Bornova-Izmir, Turkey. Hyperlipidemic patients aged ≥18 years with insulin resistance and no other components of the metabolic syndrome were included in the study. Atorvastatin 10 mg QD (after the evening meal) was administered by mouth (tablet) over a 12-week period. At baseline and after 12 weeks of treatment, insulin sensitivity was assessed using homeostasis model assessment (HOMA) index methodology. Serum lipid parameters and fasting levels of plasma glucose and insulin (FPG and FPI, respectively) were measured at the same 2 time points. The tolerability of atorvastatin was assessed using laboratory analysis and physical examination, including vital sign measurements. RESULTS Fifteen white patients (9 women, 6 men; mean [SD] age, 52 [8] years) participated in the study. No significant changes in HOMA index were found (mean [SD], 3.1 [1.5] vs 3.2 [1.9]). The lipid profile was improved significantly at 12 weeks compared with baseline (mean [SD] low-density lipoprotein cholesterol, 173.2 [21.3] vs 110.8 [43.6] mg/dL; total cholesterol, 270.9 [21.5] vs 201.2 [46.7] mg/dL; and triglycerides, 269.5 [46.3] vs 205.5 [49.3] mg/dL; all, P < 0.001). No significant change in mean (SD) plasma high-density lipoprotein cholesterol level (45.5 [6.6] vs 43.7 [8.1] mg/dL) was found. In addition, no significant changes in FPG (85.3 [12.71 vs 84.8 [10.4] mg/dL), or FPI (13.5 [9.7] vs 13.9 [10.1] μU/mL) were found. None of the patients required withdrawal of medication due to an adverse event. CONCLUSION In this pilot study in hyperlipidemic patients with insulin resistance, 12 weeks of treatment with atorvastatin 10 mg QD was effective in controlling hyperlipidemia but did not reduce the severity of insulin resistance.
Collapse
|
84
|
Tuluce K, Ozerkan F, Yakar Tuluce S, Yavuzgil O, Gurgun C, Bilgin M, Kahya Eren N, Kocabas U, Nalbantgil S, Soydas Cinar C. Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy. Cardiol J 2014; 22:94-100. [PMID: 24671901 DOI: 10.5603/cj.a2014.0025] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2013] [Revised: 03/24/2014] [Accepted: 02/23/2014] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND We evaluated the associations among the well-known atrial fibrillation (AF) predictors including P-wave dispersion (PWD), intra- and inter-atrial electromechanical dyssynchrony (EMD), left atrial (LA) phasic functions, and plasma N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) levels, in patients with hypertrophic cardiomyopathy (HCM). METHODS Seventy patients with HCM and age and sex matched 70 subjects were enrolled. PWD, LA total emptying fraction (LATEFr), active emptying fraction (LAAEFr), passive emptying fraction (LAPEFr), expansion index (LAEI) intra- and inter-atrial EMD were calculated. Levels of NT-proBNP of all subjects were determined. RESULTS Higher PWD (p = 0.006), significantly decreased LAEI (p < 0.001), LATEFr, and LAPEFr (both p values < 0.001) values and significantly increased inter-atrial (p < 0.001), LA (p = 0.001), and right atrial dyssynchrony (p < 0.001) were observed in the HCM group compared to controls. PWD was negatively correlated with LAEI (r = -0.236, p = 0.005) and LATEFr (r = -0.242, p = 0.04), however not with LAPEFr (p = 0.7), or LAAEFr (p = 0.3). Except for the LA lateral wall PA' (r = 0.283, p = 0.02), PWD was not correlated with any atrial EMD parameter. Inter-atrial dyssynchrony was related to LAEI (r = -0.272, p = 0.001), LATEFr (r = -0.256, p = 0.03), and LAPEFr (r = -0.332, p = 0.006), but not, however, to LAAEFr (p = 0.4). The plasma NT-proBNP levels of patients were not correlated with either PWD (p = 0.927) or inter-atrial dyssynchrony (p = 0.102). CONCLUSIONS PWD and inter-atrial dysynchrony seem to independently promote AF, although both are associated with LA reservoir function in HCM populations. The NT-proBNP level is not associated with these two AF predictors in patients with HCM. NT-proBNP seems to be a poor marker of atrial electrical remodeling in HCM patients.
Collapse
|
85
|
Tuluce K, Yakar Tuluce S, Isayev E, Bilgin M, Yavuzgil O, Gurgun C, Nalbantgil S, Soydas Cinar C, Ozerkan F, Brandao Da Silva D, Lehmann R, Prinz C, Horstkotte D, Faber L, Assabiny A, Apor A, Nagy A, Vago H, Toth A, Merkely B, Kovacs A, Miglioranza M, Muraru D, Peluso D, Cucchini U, Mihaila S, Naso P, Puma L, Kocabay G, Iliceto S, Badano L, Marek J, Ahmed M, Ryo K, Haugaa K, Saba S, Gorcsan J. Club 35 Moderated Poster Session - Part B: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
86
|
Karapolat H, Engin C, Eroglu M, Yagdi T, Zoghi M, Nalbantgil S, Durmaz B, Kirazlı Y, Özbaran M. Efficacy of the Cardiac Rehabilitation Program in Patients with End-Stage Heart Failure, Heart Transplant Patients, and Left Ventricular Assist Device Recipients. Transplant Proc 2013; 45:3381-5. [DOI: 10.1016/j.transproceed.2013.06.009] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2013] [Revised: 05/24/2013] [Accepted: 06/28/2013] [Indexed: 12/27/2022]
|
87
|
Ozbaran M, Yagdi T, Engin C, Erkul S, Balcioglu O, Baysal B, Nalbantgil S, Ertugay S. Long-term paracorporeal ventricular support systems: a single-center experience. Transplant Proc 2013; 45:1013-6. [PMID: 23622611 DOI: 10.1016/j.transproceed.2013.02.073] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND The Berlin Heart EXCOR is a first-generation paracorporeal, pneumatic ventricular assist device that creates pulsatile flow. It can be used for long-term support of the left and/or right ventricule during end-stage heart failure. The aim of this study was to share our clinical experience in 54 patients. METHODS Between April 2007 and August 2012, 54 patients with end-stage heart failure underwent Berlin Heart EXCOR ventricular assist device implantation, including 5 females and 9 children. Twenty-four patients (44%) were in Intermacs level 1, 11 (21%) in level 2, and 19 (35%) in level 3. Biventricular support was applied to 13 patients. Device implantation was performed with an "on pump" beating heart technique while 6 other patients underwent intervention operations while the aortic valve has under cross-clamp. Tricuspid annuloplasty was performed in 6 patients. RESULTS There was no peroperative death. Nine patients (17%) underwent re-exploration because of hemorrhage in the early postoperative period. Heart transplantation was performed in 32 patients (59%), while 10 (19%) are still under pump support with a mean follow-up of 13 months. Although 1 was successfully weaned from the system, 11 patients (20%) died during the support. Pump-head exchange was required 19 times in 17 patients because of visible thrombus or fibrin deposit in the pump head or due to membrane rupture. DISCUSSION The use of long-term paracorporeal assist devices has decreased in recent years because of the increased popularity of implantable devices that permit longer survival and a better quality of life. We believe that the Berlin Heart EXCOR has a special role because it can be used in pediatric patients and especially in critical conditions like Intermacs levels 1 and 2.
Collapse
|
88
|
Balcıoğlu Ö, Yağdı T, Engin Ç, Nalbantgil S, Ertugay S, Zoghi M, Erkul S, Baysal B, Özbaran M. The Effect of Continuous-flow Ventricle Assist Device and Support Time on Pulmonary Artery Pressure in Bridge to Heart Transplant Patients. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
89
|
Engin Y, Yağdı T, Balcıoğlu Ö, Engin Ç, Ertugay S, Nalbantgil S, Kultayev İ, Narymbetov N, Zoghi M, Özbaran M. New Generation Left Ventricular Assist Device for End Stage Heart Failure Therapy: Ege University Experience. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
90
|
İslamlı A, Cümşüdov K, Bilgin M, Yavuzgil O, Nalbantgil S, Gürgün C, Akıllı A. Transcatheter Closure of Atrial Septal Defect and the Effects on Right Ventricular Function; Strain and Strain Rate Echocardiography. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.497] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
91
|
Ertugay S, Balcıoğlu Ö, Engin AY, Oğuz E, Engin Ç, Zoghi M, Nalbantgil S, Erkul S, Yağdı T, Özbaran M. The Use of Total Artificial Heart With Example of Cases for End-Stage Heart Failure Therapy. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
92
|
Engin Y, Engin Ç, Yağdı T, Ertugay S, Nalbantgil S, Zoghi M, Balcıoğlu Ö, Öztürk P, Özbaran M. Ventricular Support Systems for End Stage Heart Failure Patients: Which patient, When? J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
93
|
Ozturk P, Engin AY, Nalbantgil S, Oguz E, Ayik F, Engin C, Yagdi T, Erkul S, Balcioglu O, Ozbaran M. Comparison of Continuous-Flow and Pulsatile-Flow Blood Pumps on Reducing Pulmonary Artery Pressure in Patients With Fixed Pulmonary Hypertension. Artif Organs 2013; 37:763-7. [DOI: 10.1111/aor.12164] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
94
|
Simsek E, Nalbantgil S, Nart D, Kilic S, Oylumlu M, Engin C, Yagdi T, Ozbaran M. Utility of left ventricular systolic strain, strain rate and torsion imaging derived from speckle-tracking echocardiography in monitoring mild acute cellular rejection in heart transplant recipients. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p2170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
95
|
Turan MN, Yaprak M, Bilgin M, Tatar E, Tamer AF, Nalbantgil S, Özkahya M, Töz H. The Evidence of Occult Hypervolemia; Improvement of Cardiac Functions After Kidney Transplantation. Ren Fail 2013; 35:718-20. [DOI: 10.3109/0886022x.2013.780616] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
96
|
Ozturk P, Engin C, Ayik F, Yagdi T, Nalbantgil S, Baysal B, Ozbaran M. Valvular procedures during ventricular assist device implantation. Transplant Proc 2013; 44:1732-4. [PMID: 22841257 DOI: 10.1016/j.transproceed.2012.05.044] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Increased experience and success with ventricular assist devices (VAD) has permitted more aggressive use in patients formerly believed to be inappropriate for mechanical circulatory support (MCS). There is no clearly proven policy to manage end-stage heart failure patients with valvular pathologies. The aim of this report was to analysis our experience with combined approach of VAD implantation and valvular procedures among patients with valvular heart disease and end-stage heart failure. METHODS We evaluated the clinical records of 67 patients who underwent MCS from April 2007 to September 2011. We identified 12 patients (17.9%) who received concomitant valvular procedures, four of whom had significant aortic insufficiency and received a simple coaptation stitch at the center to approximate the fibrous nodules of Arantius. The mechanical aortic valve was replaced with a stentless bioprosthesis in three patients. Mitral valve commissurotomy was performed in one patient with mitral stenosis and seven patients underwent tricuspit valve repair using an annuloplasty ring. RESULTS All 12 patients were males, of mean age 50.3 ± 11.5 years (range = 25-66). Eleven of them (91.6%) survived the early and late postoperative periods. Ten subjects (83.3%) continue to be supported with VAD; 1 (8.3%) was successfully bridged to transplantation. Each study participant regression of the valvular pathologies by early echocardiography demonstrated. CONCLUSION Concomitant valve surgery during VAD implantation appeared to be a reasonable option in end-stage heart failure patients with valvular heart disease.
Collapse
|
97
|
Ayik S, Gungor H, Ayik M, Engin C, Yagdi T, Nalbantgil S, Akhan G, Ozbaran M. Clinical Characteristics of Obstructive Sleep Apnea Syndrome in Heart Transplant Recipients. Transplant Proc 2013; 45:383-6. [DOI: 10.1016/j.transproceed.2012.06.076] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2012] [Accepted: 06/19/2012] [Indexed: 12/01/2022]
|
98
|
Bilgin M, Yildiz S, Gul I, Nalbantgil S. Isolated Congenital Left Ventricular Diverticulum in an Adult. Echocardiography 2012. [DOI: 10.1111/echo.12056] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
99
|
Engin Y, Engin C, Yagdi T, Nalbantgil S, Erkul S, Ertugay S, Ozbaran M. To bridge or not to bridge? Transplant Proc 2012; 44:1722-5. [PMID: 22841254 DOI: 10.1016/j.transproceed.2012.05.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
OBJECTIVE Ventricular assist devices (VAD) are an important therapy that saves the lives of candidates a waiting heart transplantation (HTx). However, there are questions about posttransplantation effects of VADs. METHODS Seventy-four patients with end-stage heart failure who underwent HTx in our clinic between February 2007 and July 2011 were divided into two groups; a bridge cohort (n = 28) and a nonbridge group comprising 46 who underwent HTx without mechanical circulatory support. There mean ages were 39.89 ± 15.66 and 38.33 ± 16.23 years respectively. Significantly more patients in the bridge group, were man displayed anemia, were treated with anticoagulation therapy, and underwent a resternotomy. In the nonbridge group, more patients needed preoperative inotropic support. RESULTS Multiple logistic regression analysis revealed preoperative renal failure (P = .007, odds ratio [OR] 27) and inotropic support (P = .006, OR: 10,222) as well as longer cardiopulmonary bypasses (≥ 130 minutes, P = .001, OR: 11,24) to be risk factors for in-hospital mortality, which was 15.2% in nonbridge and 10.7% in bridge subjects, P = .733). Major adverse events, such as renal failure, pulmonary failure, right ventricular failure, neurological event, and reoperation due to bleeding, shown similar incidences between the groups. The amount of blood transfusion was significantly higher in the bridge group (2.34 U versus 3.56 U, P = .037). The preoperative incidence of human leukocyte antigen sensitization (panel reactive antibody ≥ 10%) and grade 2R were rejection episodes in the early period were similar. CONCLUSION Early posttransplant results were not adversely or beneficially influenced by the use of VADs. Similar to other types of cardiac surgery, a patients preoperative condition seemed to be the major factor affecting mortality.
Collapse
|
100
|
Ozbaran M, Yagdi T, Engin C, Nalbantgil S, Ayik F, Oguz E, Engin Y, Özturk P. New Circulatory Support System: Heartware. Transplant Proc 2012; 44:1726-8. [DOI: 10.1016/j.transproceed.2012.05.043] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|